PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Topical application of 5% and 10% ointment aided wound healing in a streptozocin-induced diabetic mouse model [PMID:34382850]
A pH/thermosensitive gel containing QIG ethanol extract showed anti-inflammatory activity in UC mice [PMID:39435110]
Galls demonstrated a gastroprotective effect in rats [PMID:38638752]
Extract provided protective effects against acute paracetamol toxicity in mice [PMID:36936610]
In vitro activity against various pathogens including S. aureus, P. aeruginosa, Candida species, and Leptospira [PMID:38049377, PMID:25709331, PMID:30914846]
Aqueous extract inhibited cell proliferation and induced apoptosis in lung (A549), gastric (BGC823), and esophageal (KYSE-30) cancer cell lines [PMID:39086589]
Evidence summary
PubMed sources
- 1.PMID: 34382850 (2021) — Quercus infectoria gall extract aids wound healing in a streptozocin-induced diabetic mouse model. · Journal of wound care
- 2.PMID: 39435110 (2024) — Thermosensitive and pH-responsive quercus infectoria gall-containing gel with long-lasting anti-inflammatory activity for ulcerative colitis. · Heliyon
- 3.PMID: 39320377 (2025) — Identification of Fungal Species Associated with Gall Oak (Quercus infectoria) Decline in Iran. · Plant disease
- 4.PMID: 36841311 (2023) — Transcriptome analysis of gall oak (Quercus infectoria): De novo assembly, functional annotation and metabolic pathways analysis. · Genomics
- 5.PMID: 33217520 (2021) — A review of the phytochemical, pharmacological, pharmacokinetic, and toxicological evaluation of Quercus Infectoria galls.